✦ LIBER ✦

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

✍ Scribed by Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A.; Yang, Fred; Stewart, Murray W.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamics, Pharmacokinetics, Safe

✍ Matthews, Jessica E.; Stewart, Murray W.; De Boever, Erika H.; Dobbins, Robert L 📂 Article 📅 2008 🏛 Endocrine Society 🌐 English ⚖ 156 KB

Safety, tolerability, pharmacodynamics a

✍ M. A. Bush; J. E. Matthews; E. H. De Boever; R. L. Dobbins; R. J. Hodge; S. E. W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

A time course analysis of glycaemic impr

✍ Reusch, J.; Rosenstock, J.; Bush, M.; Yang, M.; Stewart, M. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 451 KB

Safet and tolerability, pharmacokinetic

✍ Seino, Y.; Nakajima, H.; Miyahara, H.; Kurita, T.; Bush, M.; Yang, F.; Stewart, 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 450 KB

The safety and tolerability of GLP-1 rec

✍ Vanita R. Aroda; Robert Ratner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

The long-acting GLP-1-receptor agonist a

✍ J. Rosenstock, F. Yang; M. Bush, J. Reusch; Stewart, M 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 441 KB